GeneDx Holdings Corp. (WGSWW)

SEC filing

GeneDx Holdings Corp.

WGSWW · CIK 1818331

4 · Sep 11, 2026 · Director, CHIEF EXECUTIVE OFFICER Stueland Katherine sold 3,692 Class A Common Stock at $84.22/unit ($310.9K); exercised options for 13.09K shares

Director, CHIEF EXECUTIVE OFFICER Stueland Katherine sold 3,692 Class A Common Stock at $84.22/unit ($310.9K); exercised options for 13.09K shares

Filed: Sep 11, 2026
Period: Sep 9, 2026
Accession: 0001689575-26-000030
Filer: GeneDx Holdings Corp.

View on SEC.gov All SEC filings

Filing document

xslF345X06/form4-09112026_080931.xml

xslF345X06/form4-09112026_080931.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4form4-09112026_080931.xml
Open SEC.gov